Specialty Medical Equipment in California
16 vendors serving California
Find specialty medical equipment vendors in California. MedIndexer lists vendors headquartered in California alongside nationwide vendors that serve California. Compare profiles, review service areas, and contact vendors directly — no middleman, no fees for buyers.
Top specialty medical equipment in California
PASSY-MUIR, INC.
Passy-Muir, Inc. manufactures the Passy Muir® Tracheostomy & Ventilator Swallowing and Speaking Valve, a one-way speaking valve device designed for tracheostomized and ventilator-dependent patients. Invented by patient David Muir, the valve redirects airflow through the vocal folds, mouth, and nose to enable voice production and improved communication. The device is indicated for both adult and pediatric patients and attaches to a standard tracheostomy tube hub or integrates in-line with ventilator circuits. Clinical evidence supports use of the Passy Muir Valve for multiple therapeutic benefits beyond speech: improved swallowing function, enhanced secretion management, improved oxygenation, restored positive airway pressure, weaning support, decannulation facilitation, restored olfaction, infection control, and pediatric speech-language development. The company also offers complementary accessories, filters, and heat-moisture exchangers (HMEs). Passy-Muir manufactures all products in the USA and holds ISO 13485:2016 certification. The company provides comprehensive clinical education through live seminars, webinars, remote in-services, and workshops targeting speech-language pathologists, respiratory therapists, nurses, and other healthcare professionals who care for tracheostomy and ventilator-dependent populations. Patient testimonials and clinical resources are published on-site. Distribution extends to international markets through authorized distributors.
Apex Dental Sleep Lab
Apex Dental Sleep Lab is a family-owned dental appliance manufacturer specializing in oral devices for obstructive sleep apnea (OSA), snoring, bruxism, and temporomandibular joint (TMJ) disorders. Based in La Mesa, California, with 30 years of industry experience, Apex designs and manufactures custom-fit intraoral mandibular repositioning appliances and related sleep medicine solutions. The company distributes multiple proprietary and partner product lines including the Kava Dorsal and Herbst devices, EMA-series appliances (EMA-NOW, EMA 3D, EMA-Milled, EMA Serena Nylon), OravanOSA, OASYS Hinge systems, OrthoApnea NOA, TAP devices, SomnoDent appliances, and QuickSplint TMJ solutions. All primary sleep apnea devices are FDA 510(k) cleared. Multiple products carry Medicare PDAC approval under HCPCS code E0486, including Kava Herbst, OASYS Hinge, and SomnoDent Herbst variants. Manufacturing capabilities include custom 3D printing, milling, thermoforming, and traditional acrylic fabrication. The company also supplies bite registration materials (Best Bite, Snap Bite), nasal stents (Mute), and diagnostic tools (Aqualizer). TMJ product lines include daytime and nighttime appliances (MORA variants, anterior deprogrammers, night positioners, hybrid nasal airway designs). Apex maintains rigorous quality assurance and positions itself as an innovator in dental sleep medicine solutions for treating mild-to-moderate sleep-disordered breathing.
NET Recovery Corp
NET Recovery Corp. develops and operates the NET Device™, an FDA-cleared transcutaneous alternating current stimulator (tACS) system for the management of opioid and kratom withdrawal symptoms. The device uses mild electrical stimulation delivered through two adhesive electrodes placed behind each ear to target the brain's reward pathway, providing rapid symptom relief typically within 20–45 minutes of treatment initiation. The company operates clinical treatment centers where patients receive device application, professional monitoring, and comprehensive support through once or twice-daily check-ins over a typical 3–4 day treatment course. NET Recovery is staffed by Advanced Practice Registered Nurses (APRNs) with specialized training in the NET Device protocol and does not dispense controlled substances. Currently available in Miami, Florida, the company offers private-pay neurostimulation services supported by peer-reviewed randomized controlled trial data demonstrating effective withdrawal symptom management and reduced post-discharge substance use. The device is indicated for use in conjunction with standard symptomatic medications and other therapies under trained clinical personnel supervision.
Sonendo, Inc.
Sonendo, Inc. is a publicly traded medical technology company specializing in innovative endodontic solutions for root canal therapy. The company develops and manufactures the GentleWave® System, a minimally invasive technology platform that utilizes advanced fluid dynamics and acoustic energy to clean and disinfect the microscopic spaces within teeth without removing tooth structure. This approach preserves dentin and reduces post-operative pain compared to traditional rotary instrumentation. Sonendo's product portfolio includes SoundSeal, a specialized sealing material, and EDTA solutions for root canal disinfection. The company also offers The Digital Office, a practice management software designed to enhance workflow efficiency for endodontists. Founded in 2006 and headquartered in Laguna Hills, California, Sonendo serves dental professionals across the U.S. and Canada, focusing on improving treatment outcomes for complex root canal systems while supporting practice growth and profitability.
HYPERBARIC MODULAR SYSTEMS, INC.
Hyperbaric Modular Systems, Inc. (HMS) is a manufacturer of clinical hyperbaric oxygen therapy (HBOT) systems, diving equipment, test and research chambers, and compressed air work systems. Founded in 1971 (formerly OxyHeal Medical Systems, Inc.), HMS designs, manufactures, installs, and provides life-cycle support for pressure chamber systems used in hospitals, outpatient wound healing centers, trauma and burn centers, research institutions, and diving operations worldwide. The company specializes in custom-designed chamber solutions for multiple sectors: medical HBOT systems for clinical applications; test and research chambers manufactured to recognized national and international safety standards; diving systems including deck decompression chambers (DDC), transportable recompression systems (TRCS), saturation systems, and containerized diving hyperbaric systems; and compressed air work (CAW) and tunnel boring machine (TBM) support systems including manlocks, shuttle systems, and saturation systems for tunneling and construction projects. HMS chambers operate 24/7/365 in healthcare facilities globally. The company has delivered specialized systems such as 1100 PSI test chambers to the US Navy under IDIQ contracts and has hosted recognized hyperbaric medical training programs. All chamber systems installed for medical use are categorized as medical devices and are designed to meet specific customer goals, regulatory requirements, and technical specifications.
Fibralign Corporation
Fibralign Corporation is a Stanford-spinout, commercial-stage biomedical device manufacturer specializing in novel therapeutic scaffolds for lymphatic and soft tissue repair. The company's flagship product, BioBridge Collagen Matrix, is an FDA 510(k)-cleared Class II device for soft tissue repair and CE-marked Class III device for surgical treatment of secondary lymphedema. BioBridge has been deployed in over 750 surgeries across 19 countries and has regulatory approval in the US, Europe, South Korea, and the Middle East. The product is a thread-like collagen scaffold designed to repair damaged lymphatic tissue based on preclinical and clinical evidence. Fibralign is developing a proprietary Nanoweave® technology platform—a 3D scaffolding technology that mimics human tissue nanostructure to direct the body's repair mechanisms—enabling a pipeline of future products across multiple high-value therapeutic applications. The company collaborates with leading international surgeons and medical institutions, including participation in the International Society of Lymphology symposia. Fibralign targets the unmet medical need in secondary lymphedema treatment, a global chronic disease without current curative options, and positions itself for broader tissue engineering applications through its Nanoweave platform.
NeuroPace, Inc.
NeuroPace, Inc. is a neurotechnology company specializing in closed-loop neuromodulation therapy for drug-resistant epilepsy. The company manufactures and markets the RNS (Responsive Neurostimulation) System, an FDA-approved implantable device designed for adults with focal epilepsy who have failed treatment with two or more anti-seizure medications. The RNS System is the only FDA-approved epilepsy device that delivers personalized, responsive treatment by detecting abnormal brain activity via EEG monitoring and delivering targeted stimulation to interrupt seizures before they occur. The system provides real-time data collection and analysis, enabling physicians to optimize individual treatment plans based on each patient's unique seizure fingerprint and triggers. The company serves epileptologists, neurosurgeons, neurologists, and comprehensive epilepsy centers across the United States. The RNS System is indicated for patients 18 years and older with localized seizure foci (no more than two) and a minimum of three seizures per month. NeuroPace provides clinical support, patient education, and healthcare provider resources including the nSight cloud-based data platform and PDMS (Patient Data Management System) for remote monitoring and device programming. The company maintains regulatory compliance with FDA approval and conducts ongoing clinical research to support therapeutic outcomes.
CLEARMIND BIOMEDICAL
Clearmind Biomedical Group develops proprietary micro-invasive surgical technologies for the treatment of intracerebral hemorrhage (ICH) and brain hemorrhage (hemorrhagic stroke). The company focuses on simplifying and streamlining operating room procedures while improving patient outcomes. Hemorrhagic stroke remains the deadliest form of stroke with mortality rates of 36–60%, and fewer than 20% of patients achieve functional independence three months post-event. Traditional brain surgery approaches produce poor outcomes despite annual treatment of over 4.6 million patients globally. Clearmind's platform addresses this clinical need through proprietary micro-invasive technology designed to reduce procedural complexity, operative time, and patient morbidity. The company collaborates closely with neurosurgeons to inform product design and ensure alignment with clinical requirements. All products emphasize quality and efficiency in neurosurgical care, with particular emphasis on improving access to ICH treatment for all patient populations.
HP
HP Inc. is an American multinational information technology company based in Palo Alto, California. Founded in 1939 by William R. Hewlett and David Packard, HP specializes in personal computers, printers, and related hardware, software, and services. The company has a rich history of innovation, starting with electronic test instruments and evolving into a leader in computing and printing technologies. HP's product offerings include a wide range of personal computers, laptops, desktops, inkjet and laser printers, and scanners. The company is known for its pioneering work in portable designs and desktop publishing, with notable products like the HP LaserJet printer and the first handheld scientific calculator, the HP-35. HP also emphasizes sustainability through hardware recycling initiatives and has formed partnerships with companies like Bang & Olufsen and Intel to enhance its product offerings. With a commitment to creativity and employee welfare, HP continues to serve consumers, small and medium-sized businesses, governments, and large enterprises globally.
M.D. Ireland Engineering, Inc.
Our mission is to efficiently and quickly satisfy our clients structural engineering requirements, prepare high quality calculations, drawings & documents for bid purposes, permit applications and construction. We cater to the commercial, residential, retail & industrial markets.
Polymer Concepts Inc
Polymer Concepts Technologies Inc. is a full-service designer, engineer, and manufacturer of polymer and fluoropolymer seals, bearings, and precision-machined components for mission-critical applications across aerospace, medical devices, life sciences (HPLC/UPLC), oil & gas, semiconductor, and specialized industrial sectors. The company specializes in highly-engineered sealing solutions including helical spring seals, V-spring seals, rotary lip seals, canted coil spring seals, and custom machined polymer components. Key capabilities include seal design services, rapid prototyping, material testing, seal failure analysis, and reverse engineering. ISO 9001:2015 certified and ITAR registered, with expertise in cryogenic seals, high-temperature/high-pressure applications, vacuum seals, and custom component manufacturing. The company serves reciprocating instruments, high-speed rotary drills and saws, medical handpieces, surgical robots, oxygen concentrators, and hospital bedstand devices.
Srs Medical Resources
[**srs medical resources** srs medical resourcessrs medical resourcessrs medical resources](https://srsmedicalresources.com/ "srs medical resources")
DYLOS CORPORATION
dylosproducts.com description comes here....
CareDx AB
CareDx is a transplant-focused diagnostic and digital health company providing comprehensive solutions across the entire transplant journey. The company delivers advanced diagnostics including rejection monitoring tests and HLA typing kits, digital health platforms, and transplant pharmacy services. CareDx reports performing over 1 million rejection monitoring tests annually, selling approximately 200,000 HLA typing kits per year, and filling 150,000 prescriptions through its transplant pharmacy division. The platform serves approximately 70% of transplant centers with one or more software products. Products and solutions span diagnostic testing, digital workflow platforms, lab innovations, and clinical decision support tools. The company combines laboratory testing capabilities with software platforms designed to simplify clinical workflows and personalize patient care throughout transplant management. CareDx operates as an integrated provider offering both diagnostic services and digital health infrastructure for transplant programs, including pre-transplant evaluation, post-transplant monitoring, and rejection surveillance.
Omnilux
Omnilux is a medical equipment manufacturing company based in Napa, California, specializing in non-invasive LED light therapy devices for skin treatment. Established in 2003, it has become a leader in non-thermal phototherapy, with origins linked to the UK Paterson Institute for Cancer Research. The company is family-owned and operated, focusing on innovative and affordable skincare solutions to enhance user confidence. Omnilux offers a range of FDA-cleared products, including the Omnilux Contour Face and Omnilux Men, designed for at-home use, as well as professional devices for clinics. Their technology is validated by over 40 peer-reviewed studies and is utilized in more than 5,000 dermatology offices and aesthetic clinics worldwide. The company emphasizes the use of specific wavelengths to stimulate cellular processes like collagen production and healing, ensuring effective treatment without heat or UV light.
SetPoint Medical
SetPoint Medical develops and commercializes the SetPoint System, an FDA-approved, implantable neuroimmune modulation device for treatment of rheumatoid arthritis (RA). The company's proprietary technology stimulates the vagus nerve to activate the body's natural anti-inflammatory pathways and restore immune balance, offering a device-based therapeutic alternative to conventional biologics and targeted synthetic drugs. The SetPoint System is a small, wireless implant designed for adults with moderately to severely active RA who have demonstrated inadequate response or intolerance to one or more biologic or targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs). Clinical evidence from the RESET-RA pivotal trial demonstrates 60% average improvement in tender and swollen joint counts over 12 months, with 9 of 10 study participants reporting willingness to recommend the therapy. The implant delivers one minute of daily stimulation for up to ten years, requiring only weekly battery charging. SetPoint has secured FDA approval (July 2025), CMS Transitional Pass-Through Payment approval (November 2025), and raised $140 million in private financing to support US commercialization beginning in limited areas in 2025. The company is also exploring the neuroimmune modulation platform for other autoimmune indications, including relapsing-remitting multiple sclerosis. Landmark clinical results were published in Nature Medicine (January 2026). SetPoint Medical represents a novel intersection of immunology, neuroscience, and biomedical engineering, positioning neuroimmune modulation as a transformative approach in autoimmune disease management.